SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-100955
Filing Date
2024-04-18
Accepted
2024-04-18 17:23:26
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 d798591d424b5.htm 424B5 458448
2 EX-FILING FEES d798591dexfilingfees.htm EX-FILING FEES 32843
3 GRAPHIC g798591g00a02.jpg GRAPHIC 51184
4 GRAPHIC g798591g00a52.jpg GRAPHIC 50664
5 GRAPHIC g798591g00a57.jpg GRAPHIC 132722
6 GRAPHIC g798591g00a83.jpg GRAPHIC 54322
  Complete submission text file 0001193125-24-100955.txt   871906
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-278726 | Film No.: 24855098
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)